Nurix Therapeutics Files Annual Report
Ticker: NRIX · Form: ARS · Filed: Mar 27, 2026 · CIK: 0001549595
Sentiment: neutral
Topics: annual-report, pharmaceuticals, sec-filing
TL;DR
Nurix Therapeutics filed its ARS for FY25 ending Nov 30, 2025. Check it for performance details.
AI Summary
Nurix Therapeutics, Inc. filed an Annual Report to Security Holders (ARS) on March 27, 2026, for the period ending November 30, 2025. The company, headquartered in Brisbane, CA, is involved in the Pharmaceutical Preparations industry. This filing provides a comprehensive overview of the company's performance and financial standing for the fiscal year.
Why It Matters
This filing provides shareholders and potential investors with crucial information regarding Nurix Therapeutics' financial health and operational performance over the past fiscal year.
Risk Assessment
Risk Level: low — This is a routine annual filing providing historical information, not indicating new risks.
Key Numbers
- 2025-11-30 — Fiscal Year End (The reporting period for the ARS filing.)
- 2026-03-27 — Filing Date (The date the ARS was officially filed with the SEC.)
Key Players & Entities
- Nurix Therapeutics, Inc. (company) — Filer of the ARS
- 2025-11-30 (date) — Period of Report
- 2026-03-27 (date) — Filing Date and Acceptance Date
- 1600 SIERRA POINT PKWY BRISBANE CA 94005 (address) — Mailing and Business Address
FAQ
What is the CIK number for Nurix Therapeutics, Inc.?
The CIK number for Nurix Therapeutics, Inc. is 0001549595.
What is the primary business of Nurix Therapeutics, Inc. according to the filing?
Nurix Therapeutics, Inc. is primarily involved in Pharmaceutical Preparations (SIC code 2834).
What is the state of incorporation for Nurix Therapeutics, Inc.?
Nurix Therapeutics, Inc. is incorporated in Delaware (DE).
What is the file number associated with this company's Act 34 filings?
The file number for Act 34 filings is 001-39398.
What is the size of the complete submission text file for this ARS filing?
The complete submission text file (0001140361-26-011505.txt) is 5541610 bytes.
Filing Details
This Form ARS (Form ARS) was filed with the SEC on March 27, 2026 regarding Nurix Therapeutics, Inc. (NRIX).